Target intelligence / Profile preview

Siderophore

Molecular classification
Small molecule, Chelating agent, Secondary metabolite
01

Overview

Siderophores are low-molecular-weight, high-affinity iron-chelating compounds secreted by microorganisms, such as bacteria and fungi, to sequester ferric iron from the environment. Because iron is essential for microbial metabolism but poorly soluble and sequestered by host proteins like transferrin, siderophores are critical virulence factors that allow pathogens to thrive during an infection. In clinical pharmacology, siderophores are utilized in two primary ways: as therapeutic agents themselves to treat iron overload (e.g., deferoxamine) and as delivery vehicles for antibiotics. The latter, often referred to as the 'Trojan Horse' strategy, involves conjugating a drug to a siderophore moiety to bypass the outer membrane permeability barrier of Gram-negative bacteria, a technique exemplified by the antibiotic cefiderocol. Targeting siderophore-mediated transport systems represents a promising frontier for overcoming multi-drug resistance in pathogens like Pseudomonas aeruginosa and Acinetobacter baumannii.

Other names
Microbial iron chelatorIron-binding ligandFerriophore
02

Mechanism of action

Siderophores are targeted through the 'Trojan Horse' mechanism, where an antimicrobial agent is chemically conjugated to a siderophore to facilitate active transport across bacterial membranes via specific iron-uptake transporters. Additionally, exogenous siderophores act as therapeutic chelators by binding systemic ferric iron to form stable complexes that are subsequently excreted.

03

Biological functions

Iron acquisitionMicrobial growth and survivalPathogenesisIron homeostasisMetal ion transport
04

Disease associations

InfectionIron overloadCystic fibrosisSepsisHemochromatosis
05

Safety considerations

NephrotoxicityOtotoxicityRisk of secondary infections (siderophilic bacteria)Injection site reactionsNeutropenia (with some chelators)
06

Interacting drugs

Cefiderocol

5 more in the full profile.

07

Biomarkers

Serum iron levelsSerum ferritinTotal iron-binding capacity (TIBC)Pathogen-specific siderophore detection (e.g., Pyoverdine, Enterobactin)

Beyond the preview

Go deeper on Siderophore.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Siderophore.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call